Divestment of Entific Medical Systems (SE) to Cochlear (AU) by CapMan, Investor Growth Capital and Nobel Biocare (SE) — SEK 1,050 million

Carnegie acted as sole financial adviser to Investor Growth Capital, Capman and Nobel Biocare in the divestment of Entific Medical Systems to Cochlear, Australia. Entific develops and markets a bone anchored titanium implant system for hearing aids which is primarily used to remedy certain hearing impairments, such as conductive hearing loss and single sided deafness.March, 2005.